Skip to main content
. Author manuscript; available in PMC: 2015 Oct 7.
Published in final edited form as: Chem Soc Rev. 2015 Jun 9;44(17):6258–6286. doi: 10.1039/c4cs00511b

Figure 13.

Figure 13

Tumour-homing cells-mediated delivery of nanomedicines to the metastatic site for theranostics of metastases. Nanomedicines can be loaded into or conjugated with tumour-homing cells, such as MSCs, T cells, monocytes and macrophages, and then delivered into metastases by the tumour-homing for diagnosis and therapy of metastasis.